Showing results (641-650 of 669) with videos related to

Sort By:
Pageof 67
Hemasphere|April 25, 2025
Comparing functional and genomic-based precision medicine in blood cancer patientsLukas Kazianka, Alexander Pichler, Christiane Agreiter, et al.
Hemasphere|April 25, 2025
High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapyAndrea Manubens, Bruno Paiva, Norma C Gutiérrez, et al.
Hemasphere|April 23, 2025
Phosphatidic acid phosphatase LPIN1 in phospholipid metabolism and stemness in hematopoiesis and AMLKarin Huber, Swati Garg, Lena Schlautmann, et al.
Hemasphere|April 17, 2025
Caplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP RegistryInés Gómez-Seguí, Joan Cid, Miquel Lozano, et al.
Hemasphere|April 9, 2025
NGS-MRD negativity in post-HSCT ALL spares unnecessary therapeutic interventions triggered by borderline qPCR results without an increase in relapse riskKrystof Seferna, Michael Svaton, Andrea Rennerova, et al.
Hemasphere|April 14, 2025
Improved post-transplant outcomes since 2000 for Ph-positive acute lymphoblastic leukemia in first remission: A study from the EBMT Acute Leukemia Working PartyAli Bazarbachi, Myriam Labopin, Iman Abou Dalle, et al.
Hemasphere|March 18, 2025
Loss of CYLD promotes splenic marginal zone lymphomaAthanasios Pseftogas, Jessica Bordini, Silvia Heltai, et al.
Hemasphere|March 24, 2025
Low-risk MDS-A spotlight on precision medicine for SF3B1-mutated patientsShoshana Burke, Onima Chowdhury, Kevin Rouault-Pierre
Hemasphere|March 26, 2025
Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotypeFrancesco Rodeghiero, Lisanna Ghiotto, Luca Pontalto, et al.
Hemasphere|June 5, 2024
Human leukocyte antigen (HLA) class I expression on Hodgkin-Reed-Sternberg cells is an EBV-independent major determinant of microenvironment composition in classic Hodgkin lymphomaBerit Müller-Meinhard, Nicole Seifert, Johanna Grund, et al.
Pageof 67